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Abstract
Mismatch repair of AID-generated dU:G mispairs is critical for class switch recombination (CSR) and somatic hypermutation
(SHM) in B cells. The generation of a previously unavailable Msh2
2/2Msh6
2/2 mouse has for the first time allowed us to
examine the impact of the complete loss of MutSa on lymphomagenesis, CSR and SHM. The onset of T cell lymphomas and
the survival of Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2Msh3
2/2 mice are indistinguishable from Msh2
2/2 mice, suggesting
that MSH2 plays the critical role in protecting T cells from malignant transformation, presumably because it is essential for
the formation of stable MutSa heterodimers that maintain genomic stability. The similar defects on switching in Msh2
2/2,
Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2Msh3
2/2 mice confirm that MutSa but not MutSb plays an important role in CSR.
Analysis of SHM in Msh2
2/2Msh6
2/2 mice not only confirmed the error-prone role of MutSa in the generation of strand
biased mutations at A:T bases, but also revealed an error-free role of MutSa when repairing some of the dU:G mispairs
generated by AID on both DNA strands. We propose a model for the role of MutSa at the immunoglobulin locus where the
local balance of error-free and error-prone repair has an impact in the spectrum of mutations introduced during Phase 2 of
SHM.
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Introduction
Immunoglobulin (Ig) genes undergo somatic hypermutation
(SHM) to produce high affinity antigen binding sites and class
switch recombination (CSR). These processes allow the antibodies
to bind antigens strongly and to carry out different effector
functions and be distributed throughout the body so that they can
inactivate pathogens and other toxic substances. Both SHM and
CSR are initiated by activation-induced cytidine deaminase (AID),
which is highly expressed in germinal center B cells [1] and is
primarily targeted to antibody variable (V) and switch (S) regions.
When mistargeted, these processes lead to B cell malignancies [2].
According to a widely accepted model [3,4], in Phase 1 of this
process, AID preferentially deaminates the C residues in WRC
(W=A or T, R=A or G) hotspot motifs in antibody genes and
converts dC to dU in single stranded DNA. The uracils are then
either replicated over to produce transition mutations or processed
by short patch base excision repair (BER) to produce both
transitions and transversions. Alternatively, in the Phase 2, the
dU:G mismatches are recognized by the mismatch repair (MMR)
complex that recruits low fidelity polymerases to resolve the AID-
generated dU:G mispairs and generate additional mutations,
especially at A:T residues, in the Ig V and S regions.
In view of their importance in maintaining genomic stability
[5,6], it is paradoxical that MMR and BER play important roles in
generating the DNA mutations and double-strand breaks that are
required for SHM and CSR. MSH2 dimerizes with MSH6 or
MSH3 to form MutSa or MutSb heterodimers, respectively, that
play distinct, though partially overlapping, functions during
mismatch repair [5]. Consistent with the central role of MSH2,
genome instability has been shown to be greater in Msh2
2/2 mice
than in the absence of either of its heterodimerization partners,
MSH6 or MSH3 [7]. Msh2
2/2 mice die predominantly from T cell
lymphomas but have some intestinal tumors [8] and several
members of recently described kindreds carrying biallelic mutations
in Msh2 have developed T cell lymphomas [9]. Interestingly,
Msh6
2/2 mice exhibit a different tumor phenotype, dying
predominantly from B cell lymphomas [10], despite the fact that
MSH2 and MSH6 form a heterodimer to recognize single base
mismatches and initiate MMR. The special relevance of MSH2/
MSH6 in B cells is further evidenced by the findings that mice
deficient in either MSH2 or MSH6 exhibit comparable decreases in
CSR and losses of mutations at A:T bases [11–15]. Deficiency in
MSH3, however, did not show any significant phenotype in CSR or
SHM [12,15,16], strongly suggesting that the MSH2/MSH6 is the
critical heterodimer that initiates MMR during SHM or CSR.
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have an additional conserved domain that binds PCNA [17–20], a
sliding clamp that plays a role in many repair processes and in
SHM and CSR [21,22]. In addition, crystal structures of MutSa
bound to DNA indicate that only MSH6 interacts directly with the
mismatch [23] and other evidence suggests that MSH6 has
scaffolding functions independent of its enzymatic activity that
influence AID targeting during SHM [24]. The differences in the
tumor phenotype of the MSH2 and MSH6 deficient mice, and the
fact that they have some different functional domains, raises the
possibility that disruption of both MSH2 and MSH6 would
intensify genomic instability in B or T cells and further impair
SHM and CSR. In fact, global genomic instability was moderately
higher in Msh2
2/2Msh3
2/2 and Msh3
2/2Msh6
2/2 than in single
Msh2
2/2 mice [7], which also suggests additional functions of
MSH6 that are independent of MSH2. To further explore the
roles of MSH2 and MSH6 in tumorigenesis, in CSR and in SHM
at A:T bases, it would be useful to analyze mice simultaneously
lacking both proteins and therefore completely deficient in MutSa
complex dependent functions [7]. Additionally, since MSH2/
MSH6 might compete with the uracil DNA-glycosylase (UNG)
that initiates BER for access to the U in the dU:G mismatch
[4,25], complete deficiency of MutSa might lead to a significant
increase in BER. However, the genes for Msh2 and Msh6 are very
closely linked on chromosome 17 and mice that are homozygous
deficient in both genes have not been available. In the present
study, we generated such homozygous doubly deficient mice via
extensive breeding and examined the impact of the loss of Muta
on lymphomagenesis, SHM and CSR.
Results and Discussion
Generation of Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2
Msh3
2/2 deficient mice
The Msh2 and Msh6 genes are very closely linked on murine
chromosome 17 and are separated by a distance of less than one
megabase. Therefore, it is extremely difficult to generate double
knockout mice using the usual double heterozygous mating scheme
[7]. To circumvent this problem, we first bred Msh2
+/2 mice with
Msh6
+/2 mice that had been fully backcrossed to the C57BL/6
strain to generate Msh2
+/2Msh6
+/2 mice in which Msh2 mutant
allele and Msh6 mutant allele were in a trans position. We then inter-
bred transMsh2
+/2Msh6
+/2 mice and screened forprogeny that had
undergone meiotic recombination between these two loci so that
one locus was homozygous and the other locus was heterozygous
(Figure 1). After screening more than 300 pups, one such
Msh2
2/2Msh6
+/2 mouse was identified. This Msh2
2/2Msh6
+/2
mouse was bred with a wild type C57BL/6 mouse to generate
Msh2
+/2Msh6
+/2 mice in which the defective Msh2
2 and
Msh6
2 genes were in cis (Figure 1). This strain was further
backcrossed to C57BL/6 mice for three generations. Then, these cis
doubleheterozygousmice werebredwitheachothertogeneratethe
Msh2
2/2Msh6
2/2 doubly deficient mice at the expected frequency
of 25% (Figure 1 and data not shown). Since the Msh3 gene is on
murine chromosome 13, triple heterozygous Msh2
+/2
Msh6
+/2Msh3
+/2 were generated by breeding cis Msh2
+/2
Msh6
+/2 with Msh3
+/2 mice as a preliminary step to the generation
of triple knockout animals.
MSH2 is a limiting factor in the susceptibility to
lymphomagenesis
As shown in Figure 2, Msh2
2/2Msh6
2/2 mice had similar life
span (median survival of 4.7 months) to Msh2
2/2 mice (median
survival of 4.9 months) (log-rank test p=0.5659). This early
lethality was significantly different (log-rank test p,0.001) from the
previously reported survival of Msh6
2/2 mice, which preferentially
develop B cell lymphomas after a longer latency [10]. When
Msh2
2/2Msh6
2/2 mice became moribund, they were euthanized
and necropsied. Large tumors were observed in all animals, and
four out of four cases analyzed by immunohistochemistry were
B220
–CD3
+ T cell lymphomas (see Figure S1). The fact that
Msh2
2/2 [8] and Msh2
2/2Msh6
2/2, but not Msh6
2/2 mice [10],
develop an indistinguishable T cell lymphoma phenotype suggests
that T cells are especially susceptible to lymphomagenesis in the
absence of normal MutSa (MSH2/MSH6) and that MutSb
(MSH2/MSH3) is sufficient to protect T cells from malignant
transformation. Consistent with this idea, Msh2
2/2
Msh6
2/2Msh3
2/2 mice had similar life span (median survival of
4.9 months) to Msh2
2/2 mice (log-rank test p=0.8404). The
differences in susceptibility to malignant transformation of
Msh2
2/2 and Msh6
2/2 mice and the protective role of MSH2
in both T and B cells is further supported by the finding that in the
absence of T cells, lack of MSH2 results in B cell lymphomas,
which was otherwise obscured by the early appearance of T cell
lymphomas [26]. This does not preclude individual and distinct
functions for MSH2, and especially for MSH6 in B cells, but it
does suggest that MSH2 plays the dominant role in protecting T
and B cells from malignant transformation, presumably because it
is shared by both MutSa and MutSb. Since the deficiency of
MSH3 is associated with very late onset of lymphomas that is
indistinguishable from wildtype animals [27], MutSa appears to be
much more protective than MutSb suggesting that either the
instability in microsatellites or the single base changes that are
repaired by MutSa are more important in malignant transforma-
Figure 1. The generation of Msh2
2/2Msh6
2/2 mice. Msh2 and
Msh6 loci are separated by less than one megabase at murine
chromosome 17. The ‘‘+’’ symbol represents the wild type allele and
the ‘‘2’’ symbol represents the knockout allele. ‘‘Trans’’ indicates that
the Msh2 and the Msh6 knockout alleles are in different chromosomes,
and ‘‘Cis’’ indicates that the Msh2 and the Msh6 knockout alleles are in a
same chromosome.
doi:10.1371/journal.pone.0011182.g001
MutSa Repair in B Cells
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by MutSb.
The MSH2/MSH6 heterodimer (MutSa) is required for
efficient CSR
Numerous studies based on single mutant mice support the
notion that MSH2/MSH6 is the major MutS complex involved in
CSR and SHM. To test whether there are heterodimer-indepen-
dent functions ofMSH6 that maypositively ornegatively contribute
to CSR, Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2Msh3
2/2 mice
were used to assay CSR ex vivo and compared to single Msh2
2/2
mice. Primary splenic B cells from these mice were stimulated with
LPS to induce switching to IgG3, or with LPS and IL4 to induce
switching to IgG1. Figure S2 shows flow cytometry results from one
representative experiment in which the double knockout mice had a
reduced frequency in switching to both IgG3 and IgG1. The data
from two Msh2
2/2,f o u rMsh2
2/2Msh6
2/2,t h r e eMsh2
2/2Msh6
2/2
Msh3
2/2 mice, and their combined eleven littermate controls
showed that the double and triple deficient B cells had ,75%
reduction in the frequency of switching to IgG3 (p,0.001) and
,50% reduction in switching to IgG1 (p,0.001) compared to
the control mice (Figure 3). This reduction in the rate of CSR
was indistinguishable from the decrease detected here for MSH2
single deficient mice and comparable to what we, and others,
have previously reported for Msh2
2/2 and for Msh6
2/2 mice
[14–16,28]. This result argues against the existence of MSH2-
independent functions of MSH6 during CSR, and confirms that
the efficiencies of switching are dramatically impaired when the
MutSa complex cannot be stabilized as a heterodimer at AID-
damaged DNA. Although there appears to be a trend towards a
decrease from Msh2
2/2 to Msh2
2/2Msh6
2/2Msh3
2/2 mice, the
differences are not significant and are consistent with the earlier
finding that MutSb and MSH3 do not have an important role
in CSR [15,16].
MSH2/MSH6 heterodimer (MutSa) favors hypermutation
at A:T sites
Similarly to CSR, a requirement for both MSH2 and MSH6 to
resolve AID-generated mismatches was observed when we
analyzed SHM in Msh2
2/2Msh6
2/2 mice. In young NP-
immunized mice, unique mutations were compiled from splenic
B cells that had mutated their V186.2 gene, which is a member of
the J558 immunoglobulin gene family that dominates the response
to NP-immunization [29]. In old unimmunized mice,
unique mutations were compiled from the Jh2-Jh4 region of
B220
+PNA
high Peyer’s patch B cells, which is an intronic region
that accumulates a large number of mutations but presumably is
not subject to selective pressure during the immune response. To
calculate mutation frequencies, the accumulated number of
unique mutations were divided by the theoretical maximum
number of the corresponding type of mutation so as to correct for
base composition [30]. As shown in Figure 4A, simultaneous
deficiency of MSH2 and MSH6 produced similar effects in the
SHM of both V186.2 and Jh2-Jh4 regions. In contrast to
previously studied single deficient Msh2 [11,31,32] or Msh6
models [16,24], which exhibited reduced overall frequencies of
mutation, there was not a decrease in the overall frequency of
unique mutations in the Msh2
2/2Msh6
2/2 B cells studied here
(Figure 4A). Since MutSa complexes preserve genomic stability in
chronically stimulated B cells [33] and a survival disadvantage
might affect the overall accumulation of mutations [34,35], we can
not rule out the possibility that the combined deficiency of both
Msh2 and Msh6 made chronically stimulated B cells less efficient
in activating apoptotic checkpoint programs allowing them to
survive longer and accumulate as many mutations as wildtype
cells. However, the even more dramatic scenarios lacking both
MMR and BER (i.e. Msh2
2/2Ung
2/2 [34] and Msh6
2/2Ung
2/2
[35]) also exhibited normal overall mutation frequencies, suggest-
ing that the mechanisms downstream of AID do not introduce
additional mutations but rather modulate the initial spectrum. In
Msh2
2/2Msh6
2/2 B cells the spectrum of mutations was
Figure 2. Comparison of the survival curves among MMR
deficient mice. Msh2
2/2 (N=20), Msh2
2/2Msh6
2/2 (N=50) and
Msh2
2/2Msh6
2/2Msh3
2/2 (N=25) mice die faster than Msh6
2/2
(N=25) (log-rank test p,0.001). The survival curve of Msh6
2/2 mice
was published previously [10].
doi:10.1371/journal.pone.0011182.g002
Figure 3. Class switch recombination analysis. Msh2
2/2 (N=2),
Msh2
2/2Msh6
2/2 (N=4) and Msh2
2/2Msh6
2/2Msh3
2/2 (N=3) mice
were assayed in five independent experiments and showed a similar
decrease in the relative switching to IgG3 and to IgG1 compared to
their control littermates (N=11). The average switching of the wildtype
mice in each experiment was defined as 100% and the data shown
represent the mean 6 SD. P values were calculated using two-tailed
unpaired Student’s T tests. ***p,0.001 was considered statistically
significant; ns, no significant, p.0.05.
doi:10.1371/journal.pone.0011182.g003
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e11182Figure 4. Effects of MSH2/MSH6 deficiency on somatic hypermutation of V186.2 and Jh2-Jh4 regions. (A) Global analysis of unique
mutation frequencies corrected for base composition. All mutation frequencies were calculated according to the standardization method suggested
in SHMTool [30]. N denotes the number of animals assayed in each group. Counts of unique mutations and relative frequencies of mutations are
shown in Figure S3. Black boxes denote statistically significant increase (p,0.05) of mutation frequency compared to WT; gray boxes denote
significant decrease (p,0.05). For V186.2 region, the RT + PCR error rate was estimated to be 0.14610
22 mutations/base because one G-to-A
mutation was detected in the Cc1 segment (39 bp) adjacent to the V186.2 region. (B) The spectrum of base substitutions presented as frequencies of
mutation (x10
22 mutations/base) and corrected for base composition. The site in hotspot motifs that was scored for mutation is underlined. W = A/
MutSa Repair in B Cells
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mutations at A:T versus C:G sites was shifted in different
directions (Figure 4A), suggesting opposing effects of MMR in
the resolution of each type of mutation during the Phase 2 of
SHM.
Transitions and transversions at A:T pairs were significantly
reduced in Msh2
2/2Msh6
2/2 mice compared to their wildtype
littermates (Figure 4A and B). Since the recruitment of Polg,
which preferentially targets WA/TW motifs [36–38], is crucial
during Phase 2 of hypermutation [21,22,32] and MSH2/MSH6
can mediate its recruitment and stimulation [39], we searched for
hallmarks of impaired Polg mutation. Analysis of the spectrum of
mutations showed that targeting of A residues within WA motifs
was significantly impaired in Msh2
2/2Msh6
2/2 mice (Figure 4).
There was a less robust, though still significant, decrease in
mutations at T residues and TW motifs in the Jh2-Jh4 region, but
this was only marginally significant in the V186.2 region, most
likely due to the low number of mutations at T sites. The
preferential decrease in A:T mutations within WA/TW motifs is
consistent with previous data from Msh2
2/2 [11,31,32,40],
Msh6
2/2 [16,24] and Msh3
2/2Msh6
2/2 [12] mice and strongly
suggests that MutSa is the major contributor of A:T mutations at
the Ig locus. The presence of residual A:T mutations in the
sequences from Msh2
2/2Msh6
2/2 B cells support previous
evidence of an alternative pathway, presumably long-patch BER
since these mutations in A:T are not seen in Msh2
2/2Ung
2/2 and
Msh6
2/2Ung
2/2 mice [34,35].
The MSH2/MSH6 heterodimer (MutSa) has an error-free
repair impact in hypermutation at C:G sites
A relative increase in C:G mutations, primarily in transitions,
has been described in MMR deficient mice [11–13,16,
24,31,32,40,41], but it is not clear if this can be explained solely
by the dramatic reduction of mutations at A:T sites or if there is
also an absolute increase in the frequency of C:G mutations. This
question was recently examined in B cells from Msh2
2/2 mice,
where a relative, but not an absolute, increase of transitions at C:G
sites was reported [40]. In Msh2
2/2Msh6
2/2 mice, however, we
found both a relative and an absolute increase in the frequency of
transition mutations at C:G pairs within WRC/GYW hotspots
(Figure 4A and S3). One possible explanation for the discrepancy
between the absolute frequencies of C:G mutations from the single
and the double knockout may lay, as discussed before, in the
overall increase in C:G mutations observed in Msh2
2/2Msh6
2/2
mice compared to Msh2
2/2 mice [40]. This increase in C:G
transitions can most readily be explained by replication of dU:G
lesions that were no longer detected and processed by the missing
MMR proteins to introduce C-to-T or G-to-A mutations
(Figure 5). This suggests that in wildtype mice MMR carries out
error-free repair of some of the uracils by copying with fidelity the
opposing G during the mutagenic patch-repair mechanism that
mobilizes Polg to cause error-prone mutations in A:T sites
(Figure 5). Such a possibility is in fact consistent with the much less
error-prone activity of Polg when copying C:G pairs compared to
its clear error-prone tendency when using T as template [42].
As a consequence of the accumulation of unrepaired AID-
generated mutations at WRC/GYW hotspots and the loss of A:T
mutations (Figure 4A and 4B), both V186.2 and Jh2-Jh4 sequences
from Msh2
2/2Msh6
2/2 mice exhibited a more restricted pattern in
the distribution of mutations compared to wiltdtype (Figure 4C).
Similar results in single Msh2
2/2 [11,32] and Msh6
2/2 mice [16,24]
support our interpretation that in the absence of MMR some of
the entry points for AID activity remain as mismatches until
replication.
On the other hand, the absolute frequency of transversions at
C:G sites was not affected in the absence of MSH2/MSH6
(Figure 4A). Since BER is a major contributor of transversions at
C:G pairs [43], this unaltered resolution of certain dU:G
mismatches into transversions is consistent with continued error-
prone BER activity that is independent of MMR and is not
enhanced in the absence of MSH2/MSH6. This result suggests
that there is little competition between these two repair processes
as they act on the Ig locus to deal with AID induced mutations and
supports previous evidence for a noncompetitive model [40]. Our
data does not rule out the existence of a cooperation between
MSH2 and UNG in generating some C:G transversions [40,44],
but does suggest that the impact of such synergistic mechanism can
be masked by the independent activity of error-prone BER in the
absence of both MSH2 and MSH6.
Strand bias signatures in Msh2
2/2Msh6
2/2 mice
Polg is known to be responsible for the A&T strand bias
signature of SHM (mutations of A exceeding mutations of T)
[36–38], which results from the preferential targeting of A
nucleotides for mutation within WA motifs on the non-transcribed
strand (Figure 5). Here, we found that both V186.2 and Jh2-Jh4
regions from wildtype mice exhibited the expected significant
A&T( p,0.001) and WA&TW bias (p,0.001) (Figure 4A and B).
However, the dramatic decrease of A:T mutations in
Msh2
2/2Msh6
2/2 B cells made this strand bias undetectable
(A<T and WA<TW, p$0.1708) (Figure 4B), suggesting that
Phase 2 mutations were introduced by a preferential activity of
error-prone MMR on the nontranscribed strand (Figure 5).
As described above, transitions at C within WRC sites were
increased in Msh2
2/2Msh6
2/2 mice (Figure 4), which could be
attributable to unrepaired mutations in the nontranscribed strand.
This increase was comparable to the increase in transitions at G
within the complementary GYW motif, which reflects the
targeting of WRC in the transcribed strand. This observation
supports the notion that error-free MMR of dU:G mispairs occurs
in both strands, as opposed to the previously discussed MMR
error-prone activity that preferentially targets A sites in the
nontranscribed strand (Figure 5).
Independently of the observation that MMR affected the
processing of dU:G mispairs on both strands, in both WT and
double-deficient mice the V186.2 region exhibited an intrinsic strand
bias of mutations at WRC on the transcribed strand (compiled as
GYW mutations) exceeding mutations at WRC on the nontran-
s c r i b e ds t r a n d( F i g u r e4 ,GYW.WRC, p,0.05). The intronic Jh2-
Jh4 region, however, did not show this bias in C:G or hotspot
mutations.Similarly,theexistenceofasubtleG.CbiasduringSHM
has been recently revealed in antigen-selected V(D)Js but not in non-
antigen selected JH4 introns [38]. Since recent in vivo evidence
suggests that AID shows an initial preference for C sites on the
nontranscribed strand (initial C.G bias) [34,35,45], it still remains
unclear how the repair process is able to override this initial bias and
p r o m p tas c e n a r i ow i t hn ob i a s( C <G) or a subtle G.Cb i a s .
According to the mutation spectrum described here for
T, R = A/G and Y = C/T. (C) Distribution of mutations in the V186.2 (273 bp) and Jh2-Jh4 (693 bp) regions. The x-axis indicates the mutation
positioning and the y-axis indicates the frequency of sequences mutated at each site. Mutation data from wildtype or Msh2
2/2Msh6
2/2 mice is
presented above or below the x-axis, respectively.
doi:10.1371/journal.pone.0011182.g004
MutSa Repair in B Cells
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2/2Msh6
2/2 mice, it seems unlikely that MMR is responsible
for this because the patterns of C<G in the Jh2-Jh4 region or G.C
in the V186.2 region were preserved even in the absence of MutSa.
The interpretation of these findings could be further complicated if
the interplay between MMR and BER to repair AID induced
mutations differs between G1/G2 phases of the cell cycle, when there
is no postreplicative repair, and S, when uracils may be introduced
genome wide as a result of normal replication [3,4,25,44,46].
The idea that mismatches at G or C in the immunoglobulin
locus may undergo error-free repair [13,32,47] and the existence
of a balance between error-prone and error-free repair have been
raised before [48]. Here, we present evidence suggesting that a
significant number of AID-generated uracils in both strands of the
immunoglobulin locus can be repaired with high fidelity by MutSa
complexes. This error-free repair appears to be locally balanced
with a strand biased error-prone introduction of mutations at A:T
sites, which is largely impaired in the absence of MutSa
complexes. CSR is also severely affected in mice lacking MutSa
complexes, although a number of switching events remain,
presumably due to the unique action of BER. In summary, the
overall impairment of the immune response and the increased
susceptibility to lymphomagenesis that is associated with the
absence of MSH2/MSH6 heterodimers highlight the critical role
of MutSa in the generation of antibody diversity in B cells and the
protection from malignant transformation of both B and T cells.
Materials and Methods
Mice
The single Msh2
2/2, Msh6
2/2 and Msh3
2/2 mouse lines were
generated and reported previously [10,27,49]. These mice were
fully backcrossed to C57BL/6 (The Jackson Laboratory) in a
barrier facility and used in this study to generate the double
Msh2
2/2Msh6
2/2 and triple Msh2
2/2Msh6
2/2Msh3
2/2 mice.
All mouse experiments were approved by the Albert Einstein
College of Medicine Animal Use Committee (Protocol number
20080801).
Survival Curves
The life spans of Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2
Msh3
2/2 mice were compared with those of contemporary
Msh2
2/2 mice and previously published Msh6
2/2 mice [10].
Log-rank (Mantel-Cox) test from GraphPad Prism 5.0a was used to
perform multiple comparisons of the survival curves and their
overall trend.
Ex vivo Class-Switching Assay
Splenic B cells were obtained from 6- to 10-week-old mice after
complement-mediated T cell depletion [28] and 0.5610
6 cells/ml
were stimulated with 50 mg/ml LPS (Sigma) or 50 mg/ml LPS and
50 ng/ml rIL-4 (R&D) for four days. Surface IgM and IgG were
Figure 5. Model for MMR resolution of AID-generated dU:G mispairs. In the DNA deamination model, MSH2/MSH6 recognizes the initial
AID-generated dU:G lesion, the damaged strand is excised by Exo1, and Polg is preferentially recruited to the nontranscribed strand (NTS) to generate
mutations at A sites within WA motifs. Fewer T sites within TW motifs are mutated, contributing to the singular A&T and WA&TW biases that
characterize SHM and reflect the reduced targeting of A sites by Polg in the transcribed strand (TS). We highlight here the error-free repair effect of
MMR at the dU:G mispairs within the excised patch, which is revealed in Msh2
2/2Msh6
2/2 mice by a significant increase in unrepaired dU:G lesions
that are replicated as transitions at C:G sites in WRC/GYW hotspots (i.e. C-to-T within WRC in the NTS, and G-to-A within GYW as a reflection of C-to-T
mutations in the TS).
doi:10.1371/journal.pone.0011182.g005
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software (Treestar).
Hypermutation Analysis
To assay SHM in the V186.2 region, 2-month-old mice were
immunized intraperitoneally with (4-hydroxy-3-nitrophenyl)acetyl
(NP)30-CGG (chicken gamma globulin) (BioSearch Technologies)
in alum (Pierce) and boosted 4 weeks after primary immunization.
One week after the boost, RNA was extracted from splenic B cells
with TRIzol (Invitrogen) and cDNA was synthesized using
oligo(dT) and AccuScript high-fidelity reverse transcriptase
(Stratagene). V186.2 region rearranged to the IgG1 constant
region was amplified by nested PCR, cloned and sequenced as
previously described [22]. To assay SHM in the Jh2-Jh4 region, 6-
month-old un-immunized healthy mice were sacrificed and
Peyer’s patches were collected. DNA was extracted from sorted
B220
+PNA
high germinal center B cells and the Jh2-Jh4 intron
region was amplified, cloned, and sequenced as previously
described [24]. Alignment and analysis of unique mutations was
done using SeqMan 5.07 (DNASTAR Inc.) and SHMTool
(http://scb.aecom.yu.edu/shmtool) [30]. As consensus sequences,
GenBank J00530.1 (nucleotides 224-496) for V186.2,
NT_166318.1 (nucleotides 25521839-25521801) for Cc1, and
NT_166318.1 (nucleotides 25620784-25620092) for Jh2Jh4 were
used. The presence of a significant A&T and WA&TW bias in
the wildtype mutation data was used for quality assessment and
largely ruled out the presence of contaminating PCR hybrids and
artifactual mutation spectra [38].
Supporting Information
Figure S1 Immunohistochemistry analysis of T cell lymphomas
in Msh2
2/2Msh6
2/2 mice. Displayed are representative images of
a lymphoma from a single animal. Tumors from four animals
yielded similar results. Mice that became moribund were
euthanized and tissues were fixed in formalin, embedded in
paraffin, and sectioned by the Histopathology Core Facility at
Albert Einstein College of Medicine. (A) Hematoxylin and Eosin
stain. For immunohistochemistry, after dewaxing, sodium-citrate
antigen retrieval, and blockage of endogenous peroxidase and
avidin/biotin activity, tissues were incubated with (B) Ready-To-
Use polyclonal rabbit anti-CD3 (Dako) or (C) rat anti-B220 clone
RA3-6B2 (BD Biosciences) at a 1:20 dilution. Appropriate
biotinylated secondary reagents were combined with DAB
chromogen (Vector) and a light hematoxylin counterstain.
Found at: doi:10.1371/journal.pone.0011182.s001 (4.07 MB TIF)
Figure S2 Representative ex vivo CSR experiment from splenic B
cells stimulated with LPS and LPS plus IL-4. Representative
FACS profiles in which splenic B cells from control, Msh2
2/2,
Msh2
2/2Msh6
2/2 and Msh2
2/2Msh6
2/2Msh3
2/2 mice were
cultured in the presence of LPS or IL4+LPS for 4 days prior to
staining for surface IgG3, IgG1 and IgM. Live cells were gated
based on FSC and SSC scatters, and the percentage of IgG
+ B
cells is indicated in each plot. Panels in columns show FACS data
from four representative animals, one for each group, assayed in
two comparable experiments.
Found at: doi:10.1371/journal.pone.0011182.s002 (1.60 MB
TIF)
Figure S3 Detailed mutations in the V186.2 and Jh2-Jh4 regions
from WT and Msh2
2/2Msh6
2/2 mice. (Left panel) Absolute
number of unique mutations classified by base pair (fr/to indicates
from y-axis to x-axis). (Middle panel) Percentages of the total
number of unique mutations. A limitation to this normalization is
that relative frequencies can be misleading and obscure changes in
absolute frequencies [30]. (Right panel) We considered mutation
frequency corrected for base composition and standardized by
SHMTool to be a more useful summary statistic [30].
Found at: doi:10.1371/journal.pone.0011182.s003 (1.40 MB TIF)
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